The efficiency of extracorporeal shock waves (SW) for Peyronie's disease (PD) is controversial.
A systematic review of the literature published between 2000 and 2019 was conducted using the PRISMA methodology.
The objective was to evaluate high-level evidence studies of extracorporeal shock wave therapy (ESWT) for urological disorders.
We included randomized controlled trials reporting outcomes of ESWT in urology.
To evaluate the effect and safety of extracorporeal shockwave therapy (ESWT) on chronic pelvic pain syndrome (CPPS)/chronic abacterial prostatitis after failure of most other modalities of treatment, the maintenance of the treatment effect for up to one year post treatment and whether the patients are in need for further sessions.
Peyronie's Disease (PD) is a disease causing psycho social trauma to the patient. Multiple treatment options are available with variable results. Extra Corporeal Shock Wave Therapy (ESWT) is a new insight into the non invasive modality of management.
Login to update email address, newsletter preferences and use bookmarks.